Report
Oliver Metzger

Sartorius Stedim Biotech : Order intake to point in the right direction

>The end of destocking, consumables drive recovery - While Q3 revenues were slightly lower than expected, the company highlighted that most customers are progressing well with their destocking programmes. The growing demand in theconsumables business more than compensates for still muted equipment demand. From a regional perspective, EMEA shows a positive development driven by the consumable business. The Americas still suffer from a high comparable base as well ...
Underlying
Sartorius Stedim Biotech SA

Sartorius Stedim Biotech is a provider of equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Co.'s solutions cover fermentation, filtration, purification, fluid management and lab technologies and membrane chromatography, including various conventional lab products to biopharmaceutical laboratories. Co.'s technologies, products and services are used to develop and manufacture medications and vaccines using biological methods. Co.'s products covers all upstream and downstream steps in the production of active pharmaceutical ingredients. It specializes in single-use products and offers technical consulting and services.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch